CUE-100 series (Cue Biopharma)

N/A

Report date: 2025/01/26 18:26:48

Base Information

Drug NameCUE-100 series (Cue Biopharma)
Drug Alias NameKRAS G12V-targeted/IL-2 fusion protein (Cue Biopharma)KRAS G12V-IL-2 fusion protein (Cue Biopharma)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-2 receptor agonistsV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitorsT-cell receptor agonists
TargetsInterleukin-2 receptorGTPase KRasT-cell receptor
Therapy Area/IndicationsHead and Neck NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCue Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunoScape Pte LtdCue Biopharma Inc
Inactive CompaniesN/A
Active IndicationsHead and Neck Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A